Intervention 290 387 4
monitoring of serum tumor markers (TMs), namely carcinoembryonic antigen, CA19-9, DUPAN-2, SPan-1
Intervention 455 478 11
Monitoring of serum TMs
Intervention 483 502 11
computed tomography
Intervention 656 811 6
we analyzed the fluctuation rates of TMs with high pretreatment positive rates, and defined the criteria of progressive disease under TM monitoring (TM-PD)
Intervention 854 982 5
we calculated the time to progression (TTP) under this TM-PD criteria, which was compared with the TTP under the RECIST criteria
Intervention 1615 1621 3
toring
Intervention 1626 1632 3
erum C
